New York University

Overview

The Master of Science in Biomaterials and Clinical Research at New York University equips students with the skills to bridge the gap between biomaterials science and clinical research. This program emphasizes the integration of biomaterials with clinical study design, evidence generation, and regulatory practices, ensuring that graduates are well-prepared to contribute to the development of safe and effective medical technologies.

What you'll study

The program typically spans 24 months, offering a comprehensive curriculum that covers essential topics in biomaterials and clinical research. Students will engage in core modules such as:

• Principles of Biomaterials
• Biocompatibility and Biological Response
• Tissue Engineering and Regenerative Approaches
• Polymers and Biopolymers for Biomedical Use
• Clinical Research Methodology
• Clinical Trials and Study Design
• Biostatistics for Health and Biomedical Research
• Epidemiology and Evidence Appraisal
• Data Management and Research Informatics
• Bioethics in Clinical and Translational Research
• Regulatory Affairs and Compliance for Medical Products
• Pathology and Translational Foundations

In addition to coursework, students will typically complete a capstone project or applied research work that integrates their biomaterials knowledge with clinical research methods, allowing for practical application of their learning.

Entry requirements

Prospective students should confirm specific academic requirements with the university. While there are no widely stated GRE, GMAT, or GPA requirements for this program, applicants must be prepared to submit relevant documentation and demonstrate proficiency in the English language through accepted tests, including the Duolingo English Test or TOEFL.

Career prospects

Graduates of the MSc in Biomaterials and Clinical Research are well-positioned for diverse career opportunities in the healthcare and biomedical industries. They may pursue roles in clinical research organizations, regulatory agencies, or medical device companies, contributing to the advancement and safety of medical technologies and therapies.